M. Salzer‐Kuntschik

Author

M. Salzer‐Kuntschik

Also Known As

M SALZER-KUNTSCHIK, M Salzer-Kuntschik, M. Salzer-Kuntschik, M. Salzer‐Kuntschik, MECHTHILD SALZER-KUNTSCHIK, Mechthild Salzer-Kuntschik

103

Publications

6.8K

Citations

H-Index

Concepts

All Affiliations

University of Vienna St Anna Children's Hospital Universität Hamburg Heinrich Heine University Düsseldorf Zentrum für Kinderheilkunde

About

M. Salzer‐Kuntschik is an author at University of Vienna specializing in medicine, oncology, and surgical oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	21	2.7K
2	Orthopaedics	11	11	1.4K
3	Health Sciences	7	7	1K
4	Cell Biology	4	4	722
5	Immunology	1	1	20

M. Salzer‐Kuntschik

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols Stefan Bielack, Beate Kempf‐Bielack, G. Delling, Journal of Clinical Oncology	2002	1.8K
Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols Leo Kager, A. Zoubek, Ulrike Pötschger, Journal of Clinical Oncology	2003	939
MIC2 is a specific marker for ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration Inge M. Ambros, Peter F. Ambros, Sabine Strehl, Cancer Specific Chromosome AberrationTumoral PathologyY ChromosomesMalignant DiseaseMic2 Gene	1991	655
Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study. K. Winkler, G. Beron, R. Kotz, Journal of Clinical Oncology Surgical OncologyCancer ManagementAdjuvant ChemotherapyPathologyPharmacotherapy	1984	349
Long-term results of the co-operative German–Austrian–Swiss osteosarcoma study group’s protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs N. Fuchs, Stefan Bielack, D. Epler, Annals of Oncology Intensive Multidrug ChemotherapyProtocol Coss-86Surgical OncologyMedicineCancer Management	1998	346
Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group Toshifumi Ozaki, Silke Flege, Matthias Kevric, Journal of Clinical Oncology	2003	341
Morphological grades of regression in osteosarcoma after polychemotherapy ? Study COSS 80 M. Salzer‐Kuntschik, G. Delling, G. Beron, Journal of Cancer Research and Clinical Oncology Morphological GradesBone ImagingMedicineSurgical PathologyBone Remodeling	1983	260
[Determination of the degree of morphological regression following chemotherapy in malignant bone tumors]. M. Salzer‐Kuntschik, Gérard Brand, G. Delling PubMed Malignant Bone TumorsTumoral PathologyBone ImagingMorphological RegressionMedicine	1983	162
Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86) K. Winkler, Stefan Bielack, G. Delling, Cancer	1990	148
Radiation therapy as local treatment in ewing's sarcoma. Results of the cooperative ewing's sarcoma studies cess 81 and cess 86 Jürgen Dunst, Rolf Sauer, J. M. V. Burgers, Cancer Adaptive RadiotherapyCooperative EwingRadiation MedicineSurgical OncologyLocal Therapy	1991	138

Page 1